Abstract
Objective To explore the effect of Xinyi Biyan Pill in adjuvant treatment of patients with chronic rhinosinusitis (CRS) and its influence on serum inflammatory factors and immune function. Methods From January 2017 to April 2020, 112 CRS patients admitted to this hospital were randomly divided into the control group (n = 52) and the study group (n = 60). The control group was treated with endoscopic sinus surgery (ESS), after the operation, levofloxacin capsules were taken orally, budesonide nasal spray was given, and the nasal cavity was flushed with normal saline; on the basis of that mentioned above, the study group was treated with Xinyi Biyan Pill orally after the surgery. The clinical efficacy and the symptom relief time of nasal congestion and runny nose, hyposmia, mucosal edema, and vesicles disappearance of the two groups after treatment were observed; the serum inflammatory factors' (C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-8 (IL-8)) and immune function indexes' (total immunoglobulin E (TIgE), eosinophil cationic protein (ECP), CD3+, CD4+, and CD4+/CD8+) expression levels before and after treatment in the two groups were detected; the recurrence of CRS after 1 year of treatment in the two groups was recorded. Result After treatment, the total clinical effective rate of the study group (92.98%) was significantly higher than that of the control group (78.00%) (P < 0.05). After treatment, the symptom relief time of nasal congestion and runny nose, hyposmia, mucosal edema, and vesicle disappearance in the study group was shorter than that in the control group (P < 0.05). After treatment, the expression levels of serum CRP, IL-6, and IL-8 in the two groups were significantly lower than those before treatment, and the study group was significantly lower than the control group (P < 0.05). After treatment, the expression levels of serum TIgE and ECP of the two groups were significantly lower than those before treatment, the expression levels of serum CD3+, CD4+, and CD4+/CD8+ of the two groups were significantly higher than those before treatment, and the study group had significant changes compared with the control group (P < 0.05). After 1 year of treatment, the recurrence rate of CRS in the study group (1.79%) was significantly lower than that in the control group (12.00%) (P < 0.05). Conclusion Xinyi Biyan Pill has a significant clinical effect in adjuvant treatment of CRS patients. It can effectively reduce the expression level of serum inflammatory factors, improve the body's immune function, and prevent short-term recurrence. It is worthy of clinical promotion.
Highlights
Chronic rhinosinusitis (CRS) is a chronic and complicated purulent inflammation commonly found in otolaryngology, with the nasal cavity and sinus mucosa as the main sites of disease
Evidence-Based Complementary and Alternative Medicine or incomplete treatment of acute sinusitis, and if the treatment of CRS is not timely and standardized, the patient’s condition will be prolonged, unhealed, and recurrent attacks for a long time, and it is easy to induce other clinical complications such as nasal polyps and cranioocular pulmonary infection, which seriously affect the quality of life and life safety of patients [3, 4]. e pathogenesis of the disease is complicated, and its proinflammatory potential is enhanced, immune function declines, and tissue remodeling is closely related to its occurrence and development [5, 6]
From January 2017 to April 2020, 112 CRS patients admitted to this hospital were randomly divided into the control group (n 52) and the study group (n 60). is study was approved by the ethics committee
Summary
Chronic rhinosinusitis (CRS) is a chronic and complicated purulent inflammation commonly found in otolaryngology, with the nasal cavity and sinus mucosa as the main sites of disease. Evidence-Based Complementary and Alternative Medicine or incomplete treatment of acute sinusitis, and if the treatment of CRS is not timely and standardized, the patient’s condition will be prolonged, unhealed, and recurrent attacks for a long time, and it is easy to induce other clinical complications such as nasal polyps and cranioocular pulmonary infection, which seriously affect the quality of life and life safety of patients [3, 4]. Xinyi Biyan Pill is an over-the-counter medicine for the clinical treatment of acute and chronic rhinitis or allergic rhinitis, which belongs to exogenous wind-heat syndrome, and it has the effects of dispelling wind and relieving internal heat or fever, detoxification inflammation, and detoxification.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Evidence-Based Complementary and Alternative Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
